Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC

Clinical trial NCT02469246 · COMPLETED

Trial details

NCT number: NCT02469246
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2015-06-29
Primary completion: 2017-12-11
Enrollment: 567

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.